参考文献/References:
［１］Baldelli R，Ettorre G，Vennarecci G，et al．Malignant insu lin－oma presenting as metastatic liver tumor．Case report and review of the literature［J］．J Exp Clin Cancer Res，２００７，２６：６０３－６０７．
［２］Hirshberg B，Cochran C，Skarulis MC，et al．Malignant insulinoma ：spectrum of unusual clinical features［J］．Cancer，２００５，１０４：２６４－２７２．
［３］王磊，赵玉沛，陈革，等．恶性胰岛素瘤的诊断和治疗（附９例报道）［J］．肝胆外科杂志，２００４，１２：８８－９０．
［４］周大勇，王建华，钱晟，等．肝动脉化疗栓塞术对富血供肝转移瘤的疗效分析［J］．介入放射学杂志，２００７，１６：１６５－１６７．
［５］Starke A，Saddig C，Mansfeld L，et al．Malignant metastatic insulinoma－postoperative treatment and follow－up［J］．World J Surg，２００５，２９：７８９－７９３．
［６］Winkelbauer FW，Nierderle B，Graf O，et al．Malignant insulinoma ：permanent hepatic artery embolization of liver metastases－preliminary results［J］．Cardiovasc Intervent Radiol，１９９５，１８：３５３－３５９．
［７］Kress O，Wagner HJ ，Wied M，et al．Transarterial chemoem bo－lization of advanced liver metastases of neuroendocrine tumors－a retrospective single－center analysis［J］．Digestion，２００３，６８：９４－１０１．
［８］Hayashi M，Takaichi K，Kariya T，et al．Malignant insulinoma which expressed a unique creatine kinase isoenzyme ：clinical value of arterial embolization as a palliative therapy［J］．InternMed，２０００，３９：４７４－４７７．
［９］Strosberg JR，Choi J，Cantor AB，et al．Selective hepatic artery embolization for treatment of patients with metastatic carcinoid and pancreatic endocrine tumors［J］．Cancer Control，２００６，１３：７２－７８．
［１０］Madoff DC，Gupta S，Ahrar K，et al．Update on the manage－ment of neuroendocrine hepatic metastases［J］．J Vasc Interv Radiol，２００６，１７：１２３５－１２５０．
［１１］Scott A，Hinwood D，Donnelly R．Radio－frequency ablation for symptom control in a patient with metastatic pancreatic insulinoma ［J］．Clin Endocrinol，２００２，５６：５５７－５５９．
［１２］Henn AR，Levine EA，McNulty W，et al．Percutaneous radiof－requency ablation of hepatic metastases for symptomatic relief of neuroendocrine syndromes［J］．AJR，２００３，１８１：１００５－１０１０．
相似文献/References:
[1]李晓光,金征宇,潘杰,等.肝动脉化疗或栓塞治疗胰腺神经内分泌肿瘤肝转移的疗效分析[J].介入放射学杂志,2010,(06):442.
LI Xiaoguang,JIN Zhengyu,PAN Jie,et al.Hepatic transarterial chemoperfusion and chemoembolization for the treatment of liver metastases from pancreatic neuroendocrine tumors：a therapeutic analysis[J].journal interventional radiology,2010,(11):442.
[2]王惠文,刘瑞宝,李晓婧,等.载药微球-TACE治疗难治性妇科恶性肿瘤肝转移12例[J].介入放射学杂志,2021,30(06):568.
WANG Huiwen,LIU Ruibao,LI Xiaojing,et al.Drug- eluting beads - TACE for the treatment of refractory liver metastases from synecological malignant tumors： preliminary results in 12 patients[J].journal interventional radiology,2021,30(11):568.
[3]于清泳,赵 辉.结直肠癌肝转移患者TACE治疗后含表皮生长因子的纤维蛋白样细胞外基质2水平及意义 [J].介入放射学杂志,2021,30(10):1035.
YU Qingyong,ZHAO Hui..The level and significance of EGF containing fibulin-like extracellular matrix protein 2 in patients with liver metastases from colorectal cancer after TACE treatment[J].journal interventional radiology,2021,30(11):1035.